Precision BioSciences, Inc.
DTIL
$6.86
$0.091.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -191.60% | 192.47% | 7.43% | -14.37% | -15.89% |
| Total Depreciation and Amortization | -5.60% | 0.59% | -3.16% | -1.28% | -6.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 341.75% | -222.95% | -23.79% | 146.03% | 181.01% |
| Change in Net Operating Assets | 78.48% | -1,543.66% | 171.92% | -102.39% | -243.73% |
| Cash from Operations | -6.11% | 26.33% | 24.67% | -6.40% | -1.98% |
| Capital Expenditure | 5.26% | -- | 100.00% | 96.88% | 34.02% |
| Sale of Property, Plant, and Equipment | -90.91% | 158.82% | 240.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.43% | -- | 100.00% | 94.00% | -- |
| Cash from Investing | 64.92% | -2,011.76% | 241.67% | 96.18% | -223.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.04% | 4,572.45% | -68.70% | -50.41% | 79.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.04% | 4,572.45% | -68.70% | -50.41% | 80.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.15% | 585.07% | 9.27% | -72.64% | 32.51% |